Detalles de la búsqueda
1.
Interleukin 2 requirement for the in vitro generation of antitumor cytotoxicity by thymocytes from melphalan-cured MOPC-315 tumor bearers.
Cancer Res
; 49(4): 870-6, 1989 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-2783557
2.
Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism.
Cancer Res
; 53(14): 3362-8, 1993 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-8391924
3.
Tumor cytotoxicity of peritoneal macrophages and peripheral blood monocytes from patients with ovarian, endometrial, and cervical cancer.
Int J Gynecol Cancer
; 9(5): 427-432, 1999 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-11240806
4.
Augmentation of impaired tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogeneic, but not autologous lymphocytes.
Cancer Immunol Immunother
; 45(1): 29-36, 1997 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-9353424
5.
Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy.
Cancer Immunol Immunother
; 32(3): 143-53, 1990.
Artículo
en Inglés
| MEDLINE | ID: mdl-2289208
6.
Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6.
Cancer Immunol Immunother
; 45(1): 37-44, 1997 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-9353425
Resultados
1 -
6
de 6
1
Próxima >
>>